| Entry |
|
|---|
| Name |
Elcatonin (JP18/INN);
Adevirock (TN) |
|---|
| Formula |
C148H244N42O47
|
|---|
| Exact mass |
3361.7994
|
|---|
| Mol weight |
3363.7742
|
|---|
| Class |
Musculo-skeletal system agent
DG03232 Osteoporosis agent
|
|---|
| Remark |
| Therapeutic category: | 3999 |
|
|---|
| Efficacy |
Antiresorptive, Regulator (calcium) |
|---|
| Comment |
calcitonin [CPD:C06865] analog
|
|---|
| Target |
CALCR [HSA:799] [KO:K04576] |
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
| hsa04380 | Osteoclast differentiation |
|
|---|
| Interaction |
|
|---|
| Structure map |
| map07047 | Osteoporosis drugs |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
H05 CALCIUM HOMEOSTASIS
H05B ANTI-PARATHYROID AGENTS
H05BA Calcitonin preparations
H05BA04 Elcatonin
D03287 Elcatonin (JP18/INN) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
39 Other agents affecting metabolism
399 Miscellaneous
3999 Others
D03287 Elcatonin (JP18/INN)
Drug groups [BR:br08330]
Musculo-skeletal system agent
DG03232 Osteoporosis agent
D03287 Elcatonin
Drug classes [BR:br08332]
Musculo-skeletal system agent
DG03232 Osteoporosis agent
D03287 Elcatonin
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Secretin receptor family
Calcitonin
CALCR
D03287 Elcatonin (JP18/INN) <JP>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D03287 Elcatonin
|
|---|
| Other DBs |
|
|---|